About this FactMed analysis covering adverse side effect reports of SUCRALFATE patients who developed BEZOAR.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 9 individuals taking SUCRALFATE reported BEZOAR to the FDA. A total of 2949 SUCRALFATE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between SUCRALFATE and BEZOAR. In doing so, we compare SUCRALFATE with other drugs that cause BEZOAR, to help you evaluate whether or not SUCRALFATE causes BEZOAR. Likewise, this page shows the most highly-reported side effects of SUCRALFATE, so you can see if BEZOAR ranks among SUCRALFATE's most well-known side effects.
Summary Statistics
Reports of SUCRALFATE causing BEZOAR: 9
Reports of any side effect of SUCRALFATE : 2949
Percentage of SUCRALFATE patients where BEZOAR is a reported side effect: 0.3052%

FDA reports of any drug causing BEZOAR : 187
Average percentage for all medicated patients where BEZOAR is reported as a complication: 0.0012%

Physician opinion on SUCRALFATE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing SUCRALFATE:
DRUG USE FOR UNKNOWN INDICATION ( 134 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 98 patients )
GASTRITIS ( 79 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 55 patients )
GASTRIC ULCER ( 48 patients )
PROPHYLAXIS ( 39 patients )
DYSPEPSIA ( 34 patients )
PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER ( 33 patients )
GASTRIC DISORDER ( 26 patients )
ULCER ( 23 patients )
GASTRITIS PROPHYLAXIS ( 15 patients )
ABDOMINAL PAIN UPPER ( 15 patients )
GASTROINTESTINAL DISORDER ( 14 patients )
DUODENAL ULCER ( 10 patients )
STOMATITIS ( 9 patients )
OESOPHAGITIS ( 9 patients )
PEPTIC ULCER ( 7 patients )
GASTRITIS EROSIVE ( 7 patients )
CROHN'S DISEASE ( 5 patients )
GASTROINTESTINAL HAEMORRHAGE ( 5 patients )
COLITIS ULCERATIVE ( 4 patients )
REFLUX OESOPHAGITIS ( 4 patients )
ERYTHEMA MULTIFORME ( 4 patients )
STOMACH DISCOMFORT ( 4 patients )
DRUG EXPOSURE DURING PREGNANCY ( 4 patients )
IRRITABLE BOWEL SYNDROME ( 4 patients )
GASTRODUODENAL ULCER ( 4 patients )
HIATUS HERNIA ( 4 patients )
HYPERCHLORHYDRIA ( 4 patients )
ABDOMINAL DISTENSION ( 3 patients )
NAUSEA ( 3 patients )
EROSIVE OESOPHAGITIS ( 3 patients )
HYPERTENSION ( 3 patients )
ILL-DEFINED DISORDER ( 3 patients )
INFLAMMATION ( 3 patients )
ABDOMINAL DISCOMFORT ( 3 patients )
ANALGESIC THERAPY ( 3 patients )
SLEEP DISORDER ( 3 patients )
HYPERTHERMIA ( 2 patients )
INFECTION PROPHYLAXIS ( 2 patients )
VARICES OESOPHAGEAL ( 2 patients )
INFLUENZA ( 2 patients )
PORTAL HYPERTENSION ( 2 patients )
MUCOSAL INFLAMMATION ( 2 patients )
DUODENAL ULCER HAEMORRHAGE ( 2 patients )
MYOSITIS ( 2 patients )
DYSPHAGIA ( 2 patients )
OESOPHAGEAL CARCINOMA ( 2 patients )
APHASIA ( 2 patients )
OESOPHAGEAL PAIN ( 2 patients )
GASTRECTOMY ( 2 patients )
REFLUX GASTRITIS ( 2 patients )
FLATULENCE ( 1 patients )
OESOPHAGEAL ULCER ( 1 patients )
CALCULUS URINARY ( 1 patients )
OROPHARYNGEAL PAIN ( 1 patients )
PHOSPHORUS METABOLISM DISORDER ( 1 patients )
ADRENOCORTICAL STEROID THERAPY ( 1 patients )
ANTACID THERAPY ( 1 patients )
HERNIA ( 1 patients )
HUNGER ( 1 patients )
RETCHING ( 1 patients )
BRONCHIOLITIS ( 1 patients )
COLITIS COLLAGENOUS ( 1 patients )
CONSTIPATION ( 1 patients )
PNEUMOCYSTIS CARINII PNEUMONIA ( 1 patients )
ABDOMINAL PAIN ( 1 patients )
POSTOPERATIVE CARE ( 1 patients )
MUSCLE SPASMS ( 1 patients )
ADENOMA BENIGN ( 1 patients )
NASOPHARYNGITIS ( 1 patients )
HAEMORRHAGE PROPHYLAXIS ( 1 patients )
EPIGASTRIC DISCOMFORT ( 1 patients )
NEOPLASM MALIGNANT ( 1 patients )
ANTIEMETIC SUPPORTIVE CARE ( 1 patients )
RENAL FAILURE CHRONIC ( 1 patients )
ERUCTATION ( 1 patients )
OESOPHAGEAL DISORDER ( 1 patients )
BARRETT'S OESOPHAGUS ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with BEZOAR:

NIFEDIPINE (16 patients)
PREDNISONE TAB (14 patients)
LORAZEPAM (13 patients)
PANTOPRAZOLE SODIUM (11 patients)
VIOXX (10 patients)
OMEPRAZOLE (10 patients)
FOLIC ACID (10 patients)
DIGOXIN (9 patients)
OCTREOTIDE ACETATE (9 patients)
SUCRALFATE (9 patients)
HYDROXYCHLOROQUINE SULFATE (9 patients)
METHOTREXATE (9 patients)
ACCUTANE (8 patients)
VENLAFAXINE HCL (8 patients)
NEXIUM (8 patients)
BUSPIRONE HCL (7 patients)
SYNTHROID (7 patients)
FOSRENOL (7 patients)
TETRACYCLINE (7 patients)
SULPIRIDE (7 patients)
INIPOMP (7 patients)
LACTULOSE (7 patients)
SERTRALINE (6 patients)
PRECOSE (6 patients)
ANAFRANIL CAP (6 patients)
ATORVASTATIN CALCIUM (6 patients)
PREDNISONE (6 patients)
CARBAMAZEPINE (6 patients)
CHOLESTYRAMINE (6 patients)
PREVACID (6 patients)
IBUPROFEN (6 patients)
METOCLOPRAMIDE (6 patients)
MINOCYCLINE HCL (6 patients)
ACETAMINOPHEN (5 patients)
CALCIUM (5 patients)
DULOXETIME HYDROCHLORIDE (5 patients)
TYLENOL (5 patients)
LOVAZA (5 patients)
MIRTAZAPINE (5 patients)
ROFECOXIB (4 patients)
PROGRAF (4 patients)
ASPIRIN (4 patients)
VENLAFAXINE (4 patients)
AZATHIOPRINE (4 patients)
CALCIUM CARBONATE (4 patients)
CARBIDOPA AND LEVODOPA (4 patients)
THEOPHYLLINE (4 patients)
ZYPREXA (4 patients)
VENLAFAXINE HYDROCHLORIDE (4 patients)
PANTOPRAZOLE (4 patients)
DULOXETINE HYDROCHLORIDE (4 patients)
SODIUM BICARBONATE (4 patients)
VITAMIN D (4 patients)
VERAPAMIL (4 patients)
TYLENOL (CAPLET) (4 patients)
MOPRAL (4 patients)
PROTHIADEN (3 patients)
SOLU-MEDROL (3 patients)
CELLCEPT (3 patients)
SEROQUEL (3 patients)
CITALOPRAM HYDROBROMIDE (3 patients)
CLOMIPRAMINE HCL (3 patients)
COLESTYRAMINE (3 patients)
DEPAKOTE (3 patients)
DIAZEPAM (3 patients)
FERROUS SULFATE TAB (3 patients)
POTASSIUM CHLORIDE (3 patients)
GLYBURIDE (3 patients)
METOPROLOL (3 patients)
TRAZODONE HCL (3 patients)
NORVASC (3 patients)
MIRALAX (3 patients)
MORPHINE (3 patients)
NEORAL (3 patients)
ONDANSERTRON HYDROCHLORIDE (2 patients)
ACETYLSALICYLIC ACID SRT (2 patients)
VITAMIN D SUPPLEMENTS (2 patients)
PANTOPRAZOLE (NGX) (PANTOPRAZOLE) UNKNOWN (2 patients)
ADALAT (2 patients)
TOBI (2 patients)
PARACETAMOL (2 patients)
ALPRAZOLAM (2 patients)
AMBIEN (2 patients)
PAXIL (2 patients)
TEGRETOL (2 patients)
RISPERIDONE (2 patients)
ONDANSETRON (2 patients)
ATENOLOL (2 patients)
ATIVAN (2 patients)
BUPROPION HCL (2 patients)
BUSPIRONE (2 patients)
CALCITRIOL (2 patients)
CALCIUM CARBONATE W/VITAMIN D NOS (2 patients)
CARAFATE (2 patients)
SULFASALAZINE (2 patients)
RENAGEL (2 patients)
[THERAPY UNSPECIFIED] (2 patients)
CLOMIPRAMINE HYDROCHLORIDE (WATSON LABORATORIES) (2 patients)
CLONAZEPAM (2 patients)
CONJUGATED OESTROGEN (2 patients)
COREG (2 patients)
COUMADIN (2 patients)
CYCLOSPORINE (2 patients)
CYMAMEMAZINE (2 patients)
CYMBALTA (2 patients)
DARVOCET (2 patients)
DEROXAT (2 patients)
DILTIAZEM HYDROCHLORIDE (2 patients)
EFFEXOR XR (2 patients)
ESOMEPRAZOLE MAGNESIUM (2 patients)
FAMOTIDINE (2 patients)
FERROUS SULFATE TABLETS (2 patients)
FGF TABLETS (2 patients)
FLAGYL (2 patients)
FORTEO (2 patients)
FUROSEMIDE (2 patients)
PROTON PUMP INHIBITORS (2 patients)
PROTON PUMP INHIBITOR (2 patients)
PENTACARINAT (2 patients)
HUMIRA (2 patients)
OCTREOTIDE (NGX) (OCTREOTIDE) UNKNOWN (2 patients)
QUETIAPINE (2 patients)
TORSEMIDE (2 patients)
INSULIN (2 patients)
PROTONIX (2 patients)
ISOSORBIDE DINITRATE (2 patients)
KALDYUM (POTASSIUM CHLORIDE) (2 patients)
NOVOLOG (2 patients)
KLONOPIN (2 patients)
VASOTEC (2 patients)
LANTUS (2 patients)
ZOLOFT (2 patients)
LITHIUM CARBONATE (2 patients)
ZELNORM (2 patients)
M.V.I. (2 patients)
MAALOX (2 patients)
MAGNESIUM CHLORIDE (2 patients)
MERCAPTOPURINE (2 patients)
MYCOPHENOLATE MOFETIL (CELLCEPT) (2 patients)
NAPROXEN (2 patients)
NATALIZUMAB (2 patients)
NEURONTIN (2 patients)
NORTRIPTYLINE HCL (2 patients)
(PROTON PUMP INHIBITORS) (1 patients)
ACHROMYCIN (1 patients)
ACTIVATED CHARCOAL (CHARCOAL, ACTIVATED) (ACTIVATED CHARCOAL) (1 patients)
ACTONEL (1 patients)
AFEDITAB (WATSON LABORATORIES) (1 patients)
ALLEGRA D 24 HOUR (1 patients)
ALLOID (1 patients)
ALLOPURINOL (1 patients)
ALTERNAGEL /00057403/ (ALUMINIUM HYDROXIDE GEL, DRIED) UNKNOWN (1 patients)
ALUMINUM HYDROXIDE TAB (1 patients)
AMANTADINE HCL (1 patients)
AMARYL (1 patients)
AMITRIPTLINE HCL (1 patients)
AMITRIPTYLINE (NGX) (1 patients)
AMITRIPTYLINE HYDROCHLORIDE (1 patients)
ATENOLOL MSD (1 patients)
ATORVASTATIN (1 patients)
ATORVASTATIN (ATORVASTATIN) (1 patients)
BACLOFEN (1 patients)
BARIUM SULFATE (1 patients)
BENADRYL (1 patients)
BENZAGEL (1 patients)
BETASERON (1 patients)
BIPERIDEN HYDROCHLORIDE (1 patients)
BROTIZOLAM (1 patients)
BUSPIRONE(BUSPIRONE) (10 MILLIGRAM, TABLETS) (1 patients)
CLINDAMYCIN (1 patients)
COLACE (1 patients)
COLCHICUM JTL LIQ (1 patients)
CONJUGATED ESTROGENS (1 patients)
CORDARONE (1 patients)
CRESTOR (1 patients)
DAPSONE (1 patients)
DEXILANT (1 patients)
DILANTIN (1 patients)
DILTIAZEM (1 patients)
DILTIAZEM HYDROCHOLORIDE (1 patients)
DIVALPROEX SODIUM (1 patients)
DOCUSATE SODIUM (DOCUSATE SODIUM) (1 patients)
DOMPERIDONE (1 patients)
DULOXETINE(DULOXETINE) (30 MILLIGRAM, CAPSULES) (1 patients)
ERYTHROMYCIN (1 patients)
ESOPRAL (1 patients)
ETHANOL (1 patients)
FIBRE, DIETARY (1 patients)
FLORINEF (1 patients)
LIPITOR (1 patients)
LISINOPRIL (1 patients)
LOTRONEX (1 patients)
MAGLAX (MAGNESIUM OXIDE) (1 patients)
MAGNESIUM (1 patients)
MAGNESIUM SULFATE (1 patients)
MECLIZINE (1 patients)
MEPROBAMATE (1 patients)
METAMUCIL-2 (1 patients)
METEZOBE (1 patients)
METFORMIN HCL (1 patients)
METOPROLOL (METOPROLOL) (1 patients)
METOPROLOL SUCCINATE (1 patients)
METOPROLOL TABLET (METOPROLOL) (1 patients)
MINOCIN (1 patients)
MINOCYCLINE (1 patients)
MIRAPEX (1 patients)
MOVIPREP (1 patients)
MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL) (1 patients)
NIFEDIPINE-DOSE-UNKNOWN-EXTENTED-RLEASE -TABLET (NIFEDIPINE) (1 patients)
NITRAZEPAM (1 patients)
Most common side effects for patients taking SUCRALFATE:
NAUSEA (258 patients)
DIARRHOEA (237 patients)
VOMITING (234 patients)
PAIN (214 patients)
DYSPNOEA (208 patients)
PYREXIA (204 patients)
PNEUMONIA (177 patients)
FATIGUE (170 patients)
ASTHENIA (164 patients)
ANAEMIA (163 patients)
CONSTIPATION (152 patients)
ABDOMINAL PAIN (147 patients)
DEHYDRATION (143 patients)
DIZZINESS (142 patients)
DEPRESSION (129 patients)
ANXIETY (128 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (120 patients)
FALL (118 patients)
HYPOTENSION (106 patients)
HYPERTENSION (105 patients)
BACK PAIN (105 patients)
OEDEMA PERIPHERAL (105 patients)
WEIGHT DECREASED (101 patients)
DRUG INEFFECTIVE (101 patients)
CHEST PAIN (99 patients)
ABDOMINAL PAIN UPPER (93 patients)
HAEMOGLOBIN DECREASED (93 patients)
THROMBOCYTOPENIA (92 patients)
ARTHRALGIA (92 patients)
GASTRITIS (91 patients)
RENAL FAILURE ACUTE (90 patients)
GASTROINTESTINAL HAEMORRHAGE (89 patients)
MALAISE (87 patients)
DYSPEPSIA (86 patients)
MYOCARDIAL INFARCTION (85 patients)
HYPOKALAEMIA (84 patients)
RENAL FAILURE (84 patients)
RASH (84 patients)
DEATH (82 patients)
SEPSIS (82 patients)
INJURY (81 patients)
WHITE BLOOD CELL COUNT DECREASED (80 patients)
COUGH (80 patients)
PLEURAL EFFUSION (79 patients)
URINARY TRACT INFECTION (78 patients)
DYSPHAGIA (76 patients)
PLATELET COUNT DECREASED (76 patients)
HEADACHE (75 patients)
SYNCOPE (74 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (73 patients)
PRURITUS (73 patients)
DECREASED APPETITE (72 patients)
INSOMNIA (70 patients)
BLOOD PRESSURE INCREASED (70 patients)
PAIN IN EXTREMITY (69 patients)
INFECTION (69 patients)
CONFUSIONAL STATE (69 patients)
ATRIAL FIBRILLATION (69 patients)
DRUG INTERACTION (68 patients)
HYPONATRAEMIA (66 patients)
DEEP VEIN THROMBOSIS (66 patients)
CONDITION AGGRAVATED (64 patients)
CARDIAC FAILURE CONGESTIVE (63 patients)
CHILLS (60 patients)
MUSCULAR WEAKNESS (59 patients)
HYPOAESTHESIA (59 patients)
OEDEMA (58 patients)
INTERSTITIAL LUNG DISEASE (57 patients)
TREMOR (56 patients)
ERYTHEMA (55 patients)
STOMATITIS (55 patients)
GAIT DISTURBANCE (53 patients)
RESPIRATORY FAILURE (53 patients)
CHOLELITHIASIS (52 patients)
PULMONARY EMBOLISM (52 patients)
CORONARY ARTERY DISEASE (52 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (52 patients)
OBESITY (51 patients)
CELLULITIS (51 patients)
MYALGIA (50 patients)
BRONCHITIS (49 patients)
CONVULSION (49 patients)
HIATUS HERNIA (49 patients)
HEPATIC FUNCTION ABNORMAL (49 patients)
OESOPHAGITIS (49 patients)
FEBRILE NEUTROPENIA (49 patients)
ALANINE AMINOTRANSFERASE INCREASED (48 patients)
NEUTROPENIA (48 patients)
LOSS OF CONSCIOUSNESS (48 patients)
RENAL IMPAIRMENT (46 patients)
METABOLIC ACIDOSIS (45 patients)
PULMONARY OEDEMA (45 patients)
MUCOSAL INFLAMMATION (45 patients)
LIVER DISORDER (45 patients)
HYPERKALAEMIA (44 patients)
DRY MOUTH (44 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (44 patients)
MELAENA (43 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (43 patients)
WEIGHT INCREASED (43 patients)
ABDOMINAL DISTENSION (42 patients)
TACHYCARDIA (42 patients)
ANOREXIA (42 patients)
CARDIOMEGALY (42 patients)
SOMNOLENCE (41 patients)
HAEMATOCRIT DECREASED (41 patients)
PANCYTOPENIA (41 patients)
HYPOXIA (40 patients)
SKIN ULCER (40 patients)
HEART RATE INCREASED (40 patients)
HAEMORRHAGE (40 patients)
FEELING ABNORMAL (40 patients)
HAEMATEMESIS (40 patients)
SEPTIC SHOCK (40 patients)
HYPERHIDROSIS (40 patients)
JOINT SWELLING (39 patients)
HYPERSENSITIVITY (39 patients)
BLOOD GLUCOSE INCREASED (39 patients)
PARAESTHESIA (39 patients)
RECTAL HAEMORRHAGE (39 patients)
MUSCLE SPASMS (39 patients)
MULTI-ORGAN FAILURE (39 patients)
CONTUSION (38 patients)
OSTEOPENIA (38 patients)
BLOOD PRESSURE DECREASED (38 patients)
CHOLECYSTITIS CHRONIC (38 patients)
ARTHRITIS (38 patients)
MALIGNANT NEOPLASM PROGRESSION (37 patients)
OSTEONECROSIS OF JAW (37 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (37 patients)
LYMPHADENOPATHY (37 patients)
DISEASE PROGRESSION (37 patients)
CATARACT (37 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (37 patients)
ECONOMIC PROBLEM (36 patients)
ASCITES (36 patients)
ATELECTASIS (36 patients)
OSTEONECROSIS (36 patients)
VISUAL IMPAIRMENT (35 patients)
HAEMATOCHEZIA (35 patients)
ASTHMA (35 patients)
ROAD TRAFFIC ACCIDENT (34 patients)
DENTAL CARIES (34 patients)
GASTRIC ULCER (34 patients)
INFLUENZA (33 patients)
CEREBROVASCULAR ACCIDENT (33 patients)
ECZEMA (33 patients)
DIABETES MELLITUS (33 patients)
OXYGEN SATURATION DECREASED (33 patients)
SINUSITIS (33 patients)
CEREBRAL INFARCTION (33 patients)
BLOOD CHOLESTEROL INCREASED (32 patients)
LEUKOPENIA (32 patients)
EPISTAXIS (32 patients)
BLOOD UREA INCREASED (32 patients)
DIVERTICULUM (32 patients)
HAEMORRHOIDS (32 patients)
OSTEOMYELITIS (31 patients)
RESPIRATORY DISTRESS (31 patients)
DRY EYE (31 patients)
SKIN LESION (31 patients)
CYSTITIS (31 patients)
HYPOPHAGIA (30 patients)
MUSCULOSKELETAL PAIN (30 patients)
BLOOD CREATININE INCREASED (30 patients)
MULTIPLE MYELOMA (30 patients)
VENTRICULAR TACHYCARDIA (30 patients)
INTESTINAL OBSTRUCTION (30 patients)
VISION BLURRED (30 patients)
UPPER RESPIRATORY TRACT INFECTION (29 patients)
CARDIAC ARREST (29 patients)
PANCREATITIS (29 patients)
EMOTIONAL DISORDER (29 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (29 patients)
ANKLE FRACTURE (29 patients)
ACUTE MYOCARDIAL INFARCTION (28 patients)
PALPITATIONS (28 patients)
ANHEDONIA (28 patients)
MEMORY IMPAIRMENT (28 patients)
WHITE BLOOD CELL COUNT INCREASED (28 patients)
UPPER RESPIRATORY TRACT INFLAMMATION (28 patients)
DYSPHONIA (28 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (28 patients)
STAPHYLOCOCCAL INFECTION (27 patients)
MENTAL DISORDER (27 patients)
RENAL FAILURE CHRONIC (27 patients)
BONE DISORDER (27 patients)
RENAL DISORDER (27 patients)
LUNG NEOPLASM (27 patients)
OVERDOSE (27 patients)
PNEUMONIA ASPIRATION (27 patients)
CARDIO-RESPIRATORY ARREST (27 patients)
OSTEOARTHRITIS (27 patients)
CARDIAC FAILURE (27 patients)
CLOSTRIDIUM DIFFICILE COLITIS (27 patients)
ARRHYTHMIA (27 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (27 patients)
PAIN IN JAW (27 patients)
ALOPECIA (26 patients)
DYSGEUSIA (26 patients)
HEPATIC FAILURE (26 patients)
SLEEP APNOEA SYNDROME (26 patients)
DELIRIUM (26 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (26 patients)
BRADYCARDIA (26 patients)
LUNG INFILTRATION (26 patients)
TARDIVE DYSKINESIA (26 patients)
OSTEOPOROSIS (25 patients)
RIB FRACTURE (25 patients)
MALNUTRITION (25 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for SUCRALFATE


Issue Description / Topic Timestamp
QUESTION
NIGHT SWEATS
I have been taking sucralfate for 2 days and have had very bad night sweats has any one experienced this. 2014-12-11 12:08:06
QUESTION
DRUG INTERACTION
Can You take oxycodone and diapause the same time as carafate? 2015-06-08 13:15:10
QUESTION
DRUG INTERACTION
Can You take oxycodone and diapause the same time as carafate? 2015-06-08 13:15:10
QUESTION
DRUG INTERACTION
Can You take oxycodone and diapause the same time as carafate? 2015-06-08 13:15:11
QUESTION
COUGH
I cougb so bad 2015-07-04 07:59:30
QUESTION
OSTEOPOROSIS
Will Sucralfate increase my osteopenia into osteoporosis? 2015-08-23 21:48:20
QUESTION
BLOOD PARATHYROID HORMONE INCREASED
I have been taking sucrafate for 4 mos. and my parathyroid level is now 111.4. Cal and vit d are ok. Is there a link? 2015-11-18 12:49:00
QUESTION
EXPIRED DRUG ADMINISTERED
My cars fate expired in 2014 ca iI still use it. 2016-06-01 11:13:23
QUESTION
SUICIDE ATTEMPT
Can it kill you if you take too much,, 2016-08-03 00:55:41
QUESTION
URINARY TRACT INFECTION
I have been taking Carafate for 4 days and woke up this morning urinating 3x in 20 minutes and have blood in my urine. I had a scheduled blood test this a.m. and tech also asked for a urine sample. It was much bloodier and had clots in it. I am waiting to hear from my Dr. 2016-09-12 09:03:02
QUESTION
INCREASED APPETITE
Can it give a baby ‌ of 3 year for appetite? 2016-10-22 06:41:34
QUESTION
ANDROGENS ABNORMAL
Can carafate increaseandrogens as a side effect? 2016-11-23 07:17:48
QUESTION
NIGHT SWEATS
I have had very bad night sweats, is this normal? I've never had night sweats like this before. 2017-02-15 08:22:05
QUESTION
EXPIRED DRUG ADMINISTERED
I. Have been prescribed sucralafate. I have some left from last script that expiration date is 2015 and it is now 2017. The seal has not been broken can I still take it? 2017-07-28 12:51:15
QUESTION
INSOMNIA
does sucralfate cause insomnia 2017-10-25 09:58:09
QUESTION
EXPIRED DRUG ADMINISTERED
I have some carafate from 2015, is it safe to take?? It's almost 2018 2017-11-01 23:16:48
QUESTION
BLOOD PRESSURE INCREASED
I've been taking sucraltate for two days and my blood pressure has gone up conseribaly. I already have hbp so I can tell the difference. 2017-11-19 12:55:42
CONCERN
BLOOD PRESSURE INCREASED
I get a headache and an increase in my Blood Pressure after taking Sucralfate. 2018-01-21 12:52:55
QUESTION
EXPIRED DRUG ADMINISTERED
Expired sucralfate 5 mos past exp date is it still safe and effective? 2018-03-25 20:46:33

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about BEZOAR and SUCRALFATE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking SUCRALFATE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in SUCRALFATE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for SUCRALFATE experts. If you are a healthcare provider experienced in prescribing SUCRALFATE, please register here.
giCould not connect: